UBS Group’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,848
| Closed | -$99.2K | – | 10350 |
|
|
2024
Q2 | $99.2K | Buy |
+17,848
| New | +$63.4K | ﹤0.01% | 6164 |
|
|
2024
Q1 | – | Sell |
-2
| Closed | -$9 | – | 10231 |
|
|
2023
Q4 | $9 | Buy |
+2
| New | +$7 | ﹤0.01% | 9127 |
|
|
2019
Q3 | – | Sell |
-1,000
| Closed | -$13K | – | 8336 |
|
|
2019
Q2 | $13K | Buy |
+1,000
| New | +$14.1K | ﹤0.01% | 6913 |
|
|
2019
Q1 | – | Sell |
-231
| Closed | -$2K | – | 8281 |
|
|
2018
Q4 | $2K | Buy |
231
+55
| +31% | +$802 | ﹤0.01% | 7821 |
|
|
2018
Q3 | $3K | Sell |
176
-544
| -76% | -$8.28K | ﹤0.01% | 7680 |
|
|
2018
Q2 | $11K | Sell |
720
-22
| -3% | -$309 | ﹤0.01% | 7089 |
|
|
2018
Q1 | $11K | Buy |
742
+232
| +45% | +$4.12K | ﹤0.01% | 6822 |
|
|
2017
Q4 | $10K | Buy |
510
+459
| +900% | +$8.96K | ﹤0.01% | 7037 |
|
|
2017
Q3 | $1K | Buy |
+51
| New | +$1.09K | ﹤0.01% | 7603 |
|
|
2017
Q2 | – | Sell |
-187
| Closed | -$4K | – | 8063 |
|
|
2017
Q1 | $4K | Sell |
187
-62
| -25% | -$1.19K | ﹤0.01% | 7099 |
|
|
2016
Q4 | $4K | Buy |
+249
| New | +$4.56K | ﹤0.01% | 7345 |
|
|
2016
Q3 | – | Sell |
-101
| Closed | -$2K | – | 7993 |
|
|
2016
Q2 | $2K | Buy |
101
+88
| +677% | +$2.34K | ﹤0.01% | 7457 |
|
|
2016
Q1 | $0 | Sell |
13
-470
| -97% | -$14.6K | ﹤0.01% | 8303 |
|
|
2015
Q4 | $17K | Buy |
483
+470
| +3,615% | +$20.4K | ﹤0.01% | 6918 |
|
|
2015
Q3 | $0 | Buy |
+13
| New | +$732 | ﹤0.01% | 8697 |
|
|
2015
Q2 | – | Sell |
-118
| Closed | -$9K | – | 8917 |
|
|
2015
Q1 | $9K | Buy |
118
+83
| +237% | +$6.53K | ﹤0.01% | 7740 |
|
|
2014
Q4 | $3K | Buy |
+35
| New | +$2.84K | ﹤0.01% | 9286 |
|
UBS Group's ALIM Position: Q3 2024 in Review
UBS Group sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 17,848 shares — an estimated $99.2K sold.
UBS Group first reported a position in ALIM in Q4 2014 and held it in 17 quarters. The position peaked at $99.2K in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- UBS Group reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- UBS Group sold 17,848 Alimera Sciences shares in Q3 2024, an estimated $99.2K.
- UBS Group first reported a position in Alimera Sciences in Q4 2014 and held it in 17 quarters.
- UBS Group's Alimera Sciences position peaked at $99.2K in Q2 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.